This round closed on 7 October 2026. The details below are from that round.
The Novo Nordisk Foundation Challenge Programme guide lists the next deadline if Novo Nordisk Foundation announces one.
Novo Nordisk Foundation
Challenge Programme 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections
14:00 CEST; Stage 1 deadline
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
The Novo Nordisk Foundation Challenge Programme 2027 funds consortia developing point-of-care diagnostics for lower respiratory tract infections and antimicrobial resistance, with grants of DKK 30-75 million (roughly €4-10 million) over six years. Main applicants must be tenured or tenure-track researchers at European universities, hospitals or non-profits, and at least one consortium member must be based in Denmark. Industry partners can collaborate but cannot receive funding, keeping the focus on proof-of-concept research rather than commercial product development.
Details
| Funder | Novo Nordisk Foundation |
| Budget | DKK 30–75 million (ca. EUR 4–10 million) per grant |
| Duration | 6 years |
| Consortium | Required — consortium of 2-4 research groups (main applicant plus 1-3 co-applicants) |
| Application | 2-stage: Stage 1 expression of interest → Stage 2 full proposal with detailed budget and panel presentation |
| Frequency | Annual |
Recently updated
catalog cleanup 2026-07-04: Oct date was not the published Stage-1 deadline per NNF
Eligibility & scope
Supports proof-of-concept research for rapid, minimally invasive, affordable point-of-care diagnostics for lower respiratory tract infections and AMR. Main applicant must be a tenured/tenure-track researcher (≥75% employment) at a European (EU/Schengen/UK) university, hospital or non-profit; at least one applicant (main or co-applicant) must be based at a Danish institution. Industry collaboration allowed but industrial partners cannot receive funding; for-profit product development is out of scope.
Who Should Apply
- •Tenured or tenure-track researchers (≥75% employment) at European universities, hospitals or non-profits
- •Consortia of 2-4 research groups, with at least one member based at a Danish institution
- •Research groups working on point-of-care diagnostics for lower respiratory tract infections or AMR
- •Teams open to industry collaboration without channeling grant funds to industrial partners
- •Applicants focused on proof-of-concept research rather than for-profit product development
Key Dates
- •Stage 1 expression of interest deadline: 7 October 2026, 14:00 CEST
- •Two-stage process: Stage 1 expression of interest, then Stage 2 full proposal with detailed budget and panel presentation
- •Six-year project duration
Tips for Applicants
- ✓Secure a Danish consortium partner early, this is a gating eligibility requirement, not just a preference.
- ✓Keep the Stage 1 expression of interest tightly scoped to proof-of-concept diagnostics; the panel screens out proposals that drift toward commercial product development.
- ✓If involving industry, clarify upfront that partners contribute expertise rather than receive funding, since this distinction is checked at both stages.
Frequently Asked Questions
How much funding does the Novo Nordisk Foundation Challenge Programme 2027 provide?
Grants range from DKK 30-75 million (approximately €4-10 million) over a six-year project period.
Who is eligible to apply as main applicant?
The main applicant must be a tenured or tenure-track researcher with at least 75% employment at a European (EU/Schengen/UK) university, hospital or non-profit institution.
Does the consortium need a Danish partner?
Yes, at least one applicant, either the main applicant or a co-applicant, must be based at a Danish institution.
Can industry partners be part of the consortium?
Industry collaboration is allowed, but industrial partners cannot receive grant funding, and for-profit product development is out of scope.
What is the application process for this call?
It is a two-stage process: a Stage 1 expression of interest followed by a Stage 2 full proposal that includes a detailed budget and panel presentation.
Related on Grantsby
- Novo Nordisk Foundation Challenge Programme, full programme guide
Eligibility, budget, success rates, application timeline, FAQ.
- Novo Nordisk Foundation Challenge Programme past winners & funded projects
Recent recipients, host institutions, and funded project titles. See who tends to win before you apply.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Challenge Programme
Novo Nordisk FoundationDKK 30–75 million (ca. EUR 4–10 million)Clinical and Independent Research
Independent Research Fund DenmarkDeadline: 24 Feb 2027Up to DKK 5,000,000 excl. overheadClinical Emerging Investigator
Novo Nordisk FoundationDeadline: 20 Jan 2027DKK 8,000,000–12,500,000 per grant (up to DKK 50M total, up to 4 grants)Exploratory Research Instrumentation
Novo Nordisk FoundationDeadline: 6 Jan 2027DKK 2 million–7.6 million per grant (total pool up to DKK 21 million)Borregaard Clinical Ascending Investigator
Novo Nordisk FoundationDeadline: 20 Jan 2027Up to DKK 11 million per grant
Browse Related
This call has closed. See what's open now.
Get matched against every open call from Novo Nordisk Foundation and the rest of the 65 funders we track, rechecked every week. 30 seconds, no signup needed to preview.
See my matches free →